Medical Pharmaceuticals

New Veeva Link MedTech Provides Real-Time Data to Optimize Scientific Engagement

by

Real-time intelligence on key experts helps drive timely, relevant engagement BARCELONA, Spain, May 18, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced Veeva Link MedTech, a data application developed for medtech companies to identify scientific experts, personalize engagement, and map activities across the healthcare ecosystem. Built on the same platform as Veeva Link Key People, … Read more

EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST

by

Halfway through 5-year study, ExoDx Prostate Test offers more accurate stratification of high- and low-risk patients compared to standard of care MINNEAPOLIS, May 18, 2023 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported interim results from a previously published prospective, randomized study of more than 1,000 patients … Read more

BD Launches World’s First Spectral Cell Sorter with High-Speed Cell Imaging

by

BD FACSDiscover™ S8 Cell Sorter First to Combine Spectral Flow Cytometry with Real-Time Imaging Technology FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to … Read more

Sector to Reach $9.61 Billion by 2030 at a 14.17% CAGR

by

DUBLIN, May 18, 2023 /PRNewswire/ — The “Global CRISPR and Cas Genes Market, By Product & Service, By Application, By End-use By Region – Industry Trends and Forecast to 2030” report has been added to  ResearchAndMarkets.com’s offering. The CRISPR and Cas Genes market, valued at USD 3.17 billion in 2022, is expected to reach USD 9.61 … Read more

European study highlights need to improve the quality of conversations about induction of labour (IoL) in clinical settings

by

Almost 1 in 2 women (49%) felt the experience of IoL differed from their expectations The majority of expectant mothers (65%) did not feel fully involved in choosing which method of IoL they prefer Findings emphasize the importance of collaborative decision-making between healthcare professionals and expectant mothers   AMSTERDAM, May 18, 2023 /PRNewswire/ — Norgine … Read more

Projected Market Value of US$ 8177.9 billion and CAGR of 31.3%

by

According to Prophecy Market Insights “Non-Alcoholic Steatohepatitis Biomarkers Market accounted for US$ 556.6 billion in 2019 and is estimated to be US$ 8177.9 billion by 2029 and is anticipated to register a CAGR of 31.3%” COVINA, Calif., May 18, 2023 /PRNewswire/ — What is the Overview of Non-Alcoholic Steatohepatitis Biomarkers Market? Non-alcoholic steatohepatitis (NASH) is the … Read more

Women’s Health Market to Reach $63.02 Billion by 2030: Grand View Research, Inc.

by

SAN FRANCISCO, May 18, 2023 /PRNewswire/ — The global women’s health market size is expected to reach USD 63.02 billion by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction of innovative novel products and the presence of a strong pipeline of women’s … Read more

Top-quality medical grade TPUs enabled by smart factory: ICP DAS

by

HSINCHU, May 18, 2023 /PRNewswire/ — Smart manufacturing & stringent process control enhance TPU quality. ICP DAS – BMP (Biomedical Polymers), a Taiwan-based supplier of medical-grade TPU (thermoplastic polyurethane), acts as a front-runner who deploys IIoT systems in a smart factory to maintain lot-to-lot consistency in TPU production. The company will showcase its prime quality … Read more

Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

by

SHANGHAI, May 18, 2023 /PRNewswire/ — Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced a strategic collaboration with UroViu Corporation (“UroViu”). Asieris Pharmaceuticals will obtain exclusive global rights to UroViu’s patented technology of portable single-use cystoscope in … Read more

ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates Towards Clinical Development

by

IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably Small-Cell Lung Cancer (SCLC) LOS ANGELES, May 18, 2023 /PRNewswire/ … Read more